Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 29, 2015 3:16 AM ET


Company Overview of Aegerion Pharmaceuticals, Inc.

Executive Profile

Sandford Drexel Smith

Interim Chief Executive Officer, Director and Member of Audit Committee, Aegerion Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 9 different industries.

See Board Relationships


Mr. Sandford Drexel Smith, also known as Sandy, BS, has been an Interim Chief Executive Officer of Aegerion Pharmaceuticals, Inc. since July 2015. Mr. Smith serves as an Executive Vice President at Sanofi Biosurgery. Mr. Smith served as President of Genzyme International Group since January 2000. He served as a Corporate Vice President and President of Genzyme Europe. In his 15 years at Genzyme, he was responsible for the successful global launch of 12 new products in ...

Corporate Headquarters

One Main Street
Cambridge, Massachusetts 02142

United States

Phone: 617-500-7867
Fax: 617-945-7968

Board Members Memberships

Director and Member of Compensation & Talent Committee
Interim Chief Executive Officer, Director and Member of Audit Committee
Director, Chairman of Compensation Committee and Member of Audit Committee


University of Denver
Unknown/Other Education
Columbia University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$55,000
Total Calculated Compensation$140,637

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Stanley T. Crooke M.D., Ph.D.Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee
Isis Pharmaceuticals, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Aegerion Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at